Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: Possible implications for prevention of vascular disease

Metabolism

Volumn 37, Issue 7, 1988, Pages 697-701

  Wilcken, David E L ^a   Dudman, Nicholas P B ^a   Tyrrell, Pauline A ^a   Robertson, Malcolm R ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; METHIONINE;

AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; HOMOCYSTEINE BLOOD LEVEL; HUMAN; VASCULAR DISEASE;

ADULT; CREATININE; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMAN; KIDNEY FAILURE, CHRONIC; MALE; METHIONINE; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T; VASCULAR DISEASES;

EID: 0023949170     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/0026-0495(88)90093-5     Document Type: Article

References (32)

1. Cardiovascular disease in hemodialysis patients
2. Occlusive arterial disease in uremic and haemodialysis and renal transplant recipients. A study of the incidence of arterial disease and of the prevalence of risk factors implicated in the pathogenesis of arteriosclerosis
3. Putative atherogenic factors in patients with chronic renal failure
4. Defective high density lipoprotein composition in patients on chronic hemodialysis
5. Plasma high-density lipoprotein concentrations in chronic-haemodialysis and renal-transplant patients
6. The influence of pre-transplant etiology of renal disease on lipoprotein lipids in female renal allograft recipients
7. Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis
8. Disorders of transsulfuration
9. The natural history of homocystinuria due to cystathionine B-synthase deficiency
10. Homocysteine-induced arteriosclerosis: The role of endothelial cell injury and platelet response in its genesis
11. Effect of sulfinpyrazone in homocysteine-induced endothelial injury and arteriosclerosis in baboons
12. The effects of homocysteine on the attachment of human arterial endothelial cells
13. The pathogenesis of coronary artery disease—A possible role for methionine metabolism
14. Homocysteinemia, ischemic heart disease, and the carrier state for homocystinuria
15. Moderate homocysteinemia—A possible risk factor for cerebrovascular disease
16. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive vascular disease
17. Methionine intolerance: A possible risk factor for coronary artery disease
18. Protein-bound homocyst(e)ine—A possible risk factor for coronary artery disease
19. Sulphur containing amino acids in chronic renal failure with particular reference to homocystine and cysteine-homocysteine mixed disulphide
20. Accumulation of sulphur-containing amino acids including cysteine-homocysteine in patients on maintenance haemodialysis
21. Homocysteine in the plasma of renal transplant recipients: Effects of cofactors for methionine metabolism
22. Ion-exchange chromatography of physiological sulphur amino acids on a highly crosslinked resin
23. Testing hypotheses: The difference between means
24. Interrelations between plasma free and protein-bound homocysteine and cysteine in homocystinuria
25. Plasma protein-bound homocyst(e)ine in patients requiring chronic haemodialysis
26. Homocystinuria: Depressed plasma serine levels
27. Folic acid responsive postmenopausal homocysteinemia
28. Homocystinuria—The effects of betaine in the treatment of patients not responsive to pyridoxine
29. Identification of 3-methylthiopropionic acid as an intermediate in mammalian methionine metabolism in vitro
30. Do patients receiving regular haemodialysis need folic acid supplements?
31. Do dialysis patients need extra folate?
32. Medical aspects of hemodialysis